DR. PETER KOLBECK, M.D.
Medical Practice in Carmichael, CA
License number
California C88598
Category
Medical Practice
Type
Specialist
License number
California G78120
Category
Medical Practice
Type
Anatomic Pathology & Clinical Pathology
Address
Address
3637 Mission Ave Bldg A STE 5, Carmichael, CA 95608
Phone
(916) 863-1496
Professional information
Dr. Peter Kolbeck, Carmichael CA - MD (Doctor of Medicine)
Specialties:
Anatomic Pathology
Address:
3637 Mission Ave STE A, Carmichael 95608
(916) 863-1496 (Phone)
(916) 863-1496 (Phone)
Certifications:
Anatomic Pathology, 1987
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Emory University
Graduated: 1982
Duke University Hospital
Emory University
Graduated: 1982
Duke University Hospital
Peter C Kolbeck, Carmichael CA
Specialties:
Pathologist
Address:
3637 Mission Ave, Carmichael, CA 95608
Coxsackie Virus Vectors For Delivery Of Nucleic Acids Encoding Antigenic Or Therapeutic Products
US Patent:
6323024, Nov 27, 2001
Filed:
Mar 27, 2000
Appl. No.:
9/403672
Inventors:
Steven M. Tracy - Omaha NE
Nora M. Chapman - Omaha NE
Peter Kolbeck - Carmichael CA
James M. Malone - Redwood CA
Nora M. Chapman - Omaha NE
Peter Kolbeck - Carmichael CA
James M. Malone - Redwood CA
Assignee:
Board of Regents of the University of Nebraska - Lincoln NE
International Classification:
C12N 1586, C12N 1563, C12N 1519, C07H 2104
US Classification:
4353201
Abstract:
The present invention is drawn to the use of attenuated Coxsackievirus cardiotropic virus vectors as efficient gene transfer vectors to deliver immunomodulatory or other biologically active proteins and/or antigenic epitopes in transient infections to aid in preventing, ameliorating, and/or ablating infectious viral heart disease and reducing, or ablating entirely, heart transplant rejection. Additionally, other organs or tissues may be targeted with specific picornaviruses. In particular, an attenuated CVB3 viral vector able to express a cytokine is provided. This cytokine-expressing viral vector is able to deliver the cytokine to a target tissue and reduce disease symptoms.
Coxsackie Virus As A Vector For Delivery Of Anti-Inflammatory Cytokines
US Patent:
6071742, Jun 6, 2000
Filed:
Mar 5, 1997
Appl. No.:
8/812121
Inventors:
Steven M. Tracy - Omaha NE
Nora M. Chapman - Omaha NE
Peter Kolbeck - Carmichael CA
James Malone - Omaha NE
Nora M. Chapman - Omaha NE
Peter Kolbeck - Carmichael CA
James Malone - Omaha NE
Assignee:
Board of Regents of the University of Nebraska - Lincoln NE
International Classification:
C12N 1586
US Classification:
4353201
Abstract:
The present invention is drawn to the use of artificially attenuated Coxsackievirus B3 cardiotropic virus vectors as efficient gene transfer vectors to deliver immunomodulatory proteins and/or antigenic epitopes in transient infections to aid in preventing, ameliorating, and/or ablating infectious viral heart disease and reducing, or ablating entirely, heart transplant rejection. Additionally, other organs or tissues may be targeted with specific picornaviruses. An attenuated CVB3 viral vector able to express a cytokine is provided. This cytokine-expressing viral vector is able to deliver the cytokine to a target tissue and reduce disease symptoms.